Viewing Study NCT04514302


Ignite Creation Date: 2025-12-25 @ 4:04 AM
Ignite Modification Date: 2025-12-26 @ 2:59 AM
Study NCT ID: NCT04514302
Status: COMPLETED
Last Update Posted: 2023-01-26
First Post: 2020-08-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody F(ab')2 Fragments (INOSARS) for Adult Patients With Mild COVID-19
Sponsor: TecSalud Investigación Clínica
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2021-12-07
Start Date Type: ACTUAL
Primary Completion Date: 2022-08-01
Primary Completion Date Type: ACTUAL
Completion Date: 2022-08-01
Completion Date Type: ACTUAL
First Submit Date: 2020-08-12
First Submit QC Date: None
Study First Post Date: 2020-08-14
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2023-01-23
Last Update Post Date: 2023-01-26
Last Update Post Date Type: ACTUAL